Home › Myelofibrosis › Ohio › Columbus
Myelofibrosis clinical trials in Columbus, OH
11 studies for Myelofibrosis are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RecruitingPhase 3
- The Ohio State University Comprehensive Cancer Center, Columbus
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RecruitingPhase 1/2
- The Ohio State University, Columbus
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RecruitingPhase 1/2
- Ohio State University, Columbus
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
RecruitingPhase 1
- The Ohio State University Comprehensive Cancer Center, Columbus
Pacritinib Effectiveness in Real-world Settings
RecruitingObservational study
- The Ohio State University, Columbus
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Ohio State University, Columbus
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
RecruitingPhase 2
- The Ohio State University, Columbus
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RecruitingPhase 1
- The Ohio State University, Columbus
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
RecruitingPhase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007), Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Columbus
Myelofibrosis trials in other cities
- Houston, TX20 studies
- New York City, NY18 studies
- Boston, MA13 studies
- Seattle, WA12 studies
- Durham, NC12 studies
- Miami, FL10 studies
- Atlanta, GA9 studies
- Salt Lake City, UT9 studies
- Cleveland, OH9 studies
- Tampa, FL9 studies
- Baldwin Park, CA9 studies
- Ann Arbor, MI8 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer54 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer26 studies
- Endometrial Cancer26 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
- Colorectal Cancer23 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.